Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longxia Li

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Delivery and Translational Research|January 8, 2024
pH and redox dual response nano-suppository for the treatment of ulcerative colitisYijun Wu, Jinfeng Song, Xiaochen Wang, et al.
ACS Applied Materials & Interfaces|November 13, 2024
Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepatocellular Carcinoma ActivityYijun Wu, Xiaochen Wang, Longxia Li, et al.
Journal of Materials Chemistry. B|October 25, 2023
Preparation and anti-tumor effects of mesoporous silica nanoparticles loaded with trifluoperazineYunfeng Ma, Longxia Li, Liufang Mo, et al.
Colloids and Surfaces. B, Biointerfaces|December 14, 2025
A H2O2-self-supplying and oxygen-evolving nanosystem for amplified chemodynamic therapy of breast cancerYijun Wu, Longxia Li, Lechen Jia, et al.
Biomaterials|May 3, 2022
Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosusQianqian Guo, Chuanrong Chen, Zhihua Wu, et al.
Journal of Biomedical Nanotechnology|April 20, 2021
Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian CarcinomaDi He, Xiaoyi Xu, Longxia Li, et al.
Journal of Nanobiotechnology|January 26, 2022
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancerLongxia Li, Di He, Qianqian Guo, et al.
Therapeutic Advances in Medical Oncology|April 8, 2026
S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancerYilizhati Maimaiti, Yulian Chen, Longxia Li, et al.
Biomedicines|December 30, 2025
Single-Cell Analysis Links C7+ Cancer-Associated Fibroblasts with Incomplete Resection in Platinum-Sensitive Relapsed Ovarian CancerLongxia Li, Shangbing Gao, Yilizhati Maimaiti, et al.
Oncotargets and Therapy|January 28, 2022
Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR PathwayFangfang Liu, Lumin Tang, Mengyu Tao, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Delivery and Translational Research|January 8, 2024
pH and redox dual response nano-suppository for the treatment of ulcerative colitisYijun Wu, Jinfeng Song, Xiaochen Wang, et al.
ACS Applied Materials & Interfaces|November 13, 2024
Preparation of Glutathione-Regulated Sorafenib Targeted Nanodrug Delivery System and Its Antihepatocellular Carcinoma ActivityYijun Wu, Xiaochen Wang, Longxia Li, et al.
Journal of Materials Chemistry. B|October 25, 2023
Preparation and anti-tumor effects of mesoporous silica nanoparticles loaded with trifluoperazineYunfeng Ma, Longxia Li, Liufang Mo, et al.
Colloids and Surfaces. B, Biointerfaces|December 14, 2025
A H2O2-self-supplying and oxygen-evolving nanosystem for amplified chemodynamic therapy of breast cancerYijun Wu, Longxia Li, Lechen Jia, et al.
Biomaterials|May 3, 2022
Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosusQianqian Guo, Chuanrong Chen, Zhihua Wu, et al.
Journal of Biomedical Nanotechnology|April 20, 2021
Functional Exosome-Mediated Delivery of Triptolide Endowed with Targeting Properties as Chemotherapy Carriers for Ovarian CarcinomaDi He, Xiaoyi Xu, Longxia Li, et al.
Journal of Nanobiotechnology|January 26, 2022
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancerLongxia Li, Di He, Qianqian Guo, et al.
Therapeutic Advances in Medical Oncology|April 8, 2026
S100A4 characterize antigen-presenting cancer-associated fibroblasts and predicts surgical outcomes in relapsed ovarian cancerYilizhati Maimaiti, Yulian Chen, Longxia Li, et al.
Biomedicines|December 30, 2025
Single-Cell Analysis Links C7+ Cancer-Associated Fibroblasts with Incomplete Resection in Platinum-Sensitive Relapsed Ovarian CancerLongxia Li, Shangbing Gao, Yilizhati Maimaiti, et al.
Oncotargets and Therapy|January 28, 2022
Stichoposide C Exerts Anticancer Effects on Ovarian Cancer by Inducing Autophagy via Inhibiting AKT/mTOR PathwayFangfang Liu, Lumin Tang, Mengyu Tao, et al.
Pageof 1